搜索临床试验以:SCD-044_Dose 1
总计16772个结果
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)终止
-
Indiana UniversityThe National Center for Complementary and Integrative Health招聘中
-
Shanghai Jiao Tong University School of Medicine未知
-
Merck Sharp & Dohme LLC完全的
-
University of ChicagoNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)完全的
-
Yousef ZakhariaUniversity of Iowa招聘中
-
Hackensack Meridian Health完全的
-
Astellas Pharma Global Development, Inc.完全的胃食管连接部 CLDN18.2 阳性腺癌 | CLDN18.2阳性食管腺癌 | CLDN18.2阳性胃腺癌德国, 拉脱维亚
-
Janssen Research & Development, LLC终止
-
Danone Research完全的Mild Hypercholesterolemic Subjects德国
-
Armauer Hansen Research Institute, EthiopiaUnited States Agency for International Development (USAID); Tulane University; Addis Continental... 和其他合作者未知
-
Merck Sharp & Dohme LLC撤销
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals America尚未招聘
-
Jonsson Comprehensive Cancer CenterNatera, Inc.; The Joseph Drown Foundation招聘中III 期直肠癌 AJCC v8 | IIIA 期直肠癌 AJCC v8 | IIIB 期直肠癌 AJCC v8 | IIIC 期直肠癌 AJCC v8 | 直肠腺癌 | IIA 期直肠癌 AJCC v8 | IIB 期直肠癌 AJCC v8 | II 期直肠癌 AJCC v8 | IIC 期直肠癌 AJCC v8 | 局部晚期直肠癌美国
-
Brighton and Sussex University Hospitals NHS TrustMedtronic Vascular完全的
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer Research完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Merck Sharp & Dohme LLC完全的
-
Jazz Pharmaceuticals完全的在已知 CYP3A4 诱导剂不存在和存在的情况下评估 Sativex 的药代动力学 | 在不存在和存在 CYP3A4 强效抑制剂的情况下评估 Sativex 的药代动力学 | 在不存在和存在 CYP2C19 抑制剂的情况下评估 Sativex 的药代动力学英国
-
John HaysSanofi未知
-
Children's Oncology GroupNational Cancer Institute (NCI)主动,不招人难治性恶性实体瘤 | 复发性恶性实体瘤 | 复发性原发性中枢神经系统肿瘤 | 难治性原发性中枢神经系统肿瘤 | 儿童实体肿瘤美国
-
Roswell Park Cancer Institute主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类耐药卵巢癌 | 铂敏感性卵巢癌 | 难治性卵巢癌 | 铂敏感性输卵管癌 | 铂敏感原发性腹膜癌 | 难治性输卵管癌 | 难治性原发性腹膜癌美国
-
National Cancer Institute (NCI)NRG Oncology完全的
-
Astellas Pharma IncAstellas Pharma Canada, Inc.完全的
-
HaEmek Medical Center, Israel未知
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Eye Institute... 和其他合作者完全的
-
Beth Israel Deaconess Medical CenterAstraZeneca完全的
-
Iuliu Hatieganu University of Medicine and PharmacyProf. Dr. I. Chiricuta Institute of Oncology完全的
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC完全的